MedTrace Logo

Compare Early With Deferred Invasive Strategy for STEMI Presenting 24-48 Hours From Symptom Onset

NCT04575012 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2020-10-05

No results posted yet for this study

Summary

The primary objective of the trial is to compare the efficacy of early with deferred invasive strategy for patients with ST-segment elevation myocardial infarction (STEMI) within 24-48h of symptom onset.

Conditions

  • ST-segment Elevation Myocardial Infarction (STEMI)

Interventions

PROCEDURE

Deferred invasive strategy

PCI on 7 to 10 days after symptom onset

PROCEDURE

Early invasive strategy

Primary PCI

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Junbo Ge, M.D. · Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-12-01
Completion
2025-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04575012 on ClinicalTrials.gov